February 19, 2018 3:38 AM ET


Company Overview of IDEA AG

Company Overview

IDEA AG develops and commercializes non-invasive targeted therapeutics applied through the skin for delivery of drugs. The company uses Transfersome cariers for transporting the established molecular weight drugs selectively into the skin. It focuses on dermatological and pain therapeutics. The company’s Diractin is a ketoprofen in the Transfersome gel for the treatment of peripheral pain. IDEA AG was founded in 1993 and is based in Munich, Germany.

Arnulfstraße 39

Munich,  80636


Founded in 1993


49 89 3246330


49 89 32463394

Key Executives for IDEA AG

Principal Scientist of Formulation and Physical Assays
Vice President of Pharmaceutical Development
Manager of Quality Assurance
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
µ-bond GmbH Europe
4 Animals AlsterScience GmbH Europe
Acousia Therapeutics GmbH Europe
Across Barriers GmbH Europe
Actinodrug Pharmaceuticals GmbH Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
NYC2012, Inc. United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact IDEA AG, please visit www.idea-ag.de. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.